Clinical Trial Update: First-in-Human Study of ISH0688: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial of ISH0688 evaluates safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects and individuals with hyperlip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• ISH0688

Snippet

Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. | Conditions: Healthy Subjects, Hyperlipidemia, Hypertriglyceridemia | Phase 1 | Status: NOT_YET_RECRUITING